Chemokine receptor binding heterocyclic compounds
US6864265B2 · kind B2 · utility
27Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2001 |
| Grant date | Mar 8, 2005 |
| Priority date | — |
| Expiry date | Sep 17, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds that bind to chemokine receptors such as CXCR4 and CCR5 demonstrate protective effects against infection of cells by human immunodeficiency virus are disclosed. These compounds contain a tertiary amine[[s]] linked to a core nitrogen via an aromatic or heteroaromatic moiety.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.